Feroscan
Feroscan specializes in the development of first-in-class personalized cytotoxics with a unique and innovative mode of action. The pipeline of the company focuses on intractable cancers; such as ovarian and triple negative breast cancers.
![Feroscan](/sites/techtransfer/files/styles/rectangle_grand_crop/public/medias/images/2021-02/Feroscan_1.png?h=81cafd79&itok=1w-kemnn)
@Feroscan
Feroscan specializes in the development of first-in-class personalized cytotoxics with a unique and innovative mode of action. The pipeline of the company focuses on intractable cancers; such as ovarian and triple negative breast cancers.
Year of creation: 2014
Line of business: Pharmaceuticals
Institut Curie: Behind the technology and R&D partner
TECHNOLOGY
Feroscan specializes in the development of first-in-class personalized cytotoxics with a unique and innovative mode of action. The pipeline of the company focuses on intractable cancers; such as ovarian and triple negative breast cancers.
APPLICATIONS
The company's pipeline targets orphan cancers in particular Ovarian lowox cancer, Triple negative breast cancer.